Blog
RSS FeedPosted by Michael Wonder on 29 Oct 2021
Public Summary Documents – July 2021 PBAC meeting
29 October 2021 - The public summary documents (positive recommendations and subsequent decisions not to recommend) from the July 2021 PBAC ...
Posted by Michael Wonder on 29 Oct 2021
PBS arrangements for tocilizumab shortage – 1 November 2021
29 October 2021 - In response to the shortages of multiple presentations of tocilizumab (Actemra) products, the PBAC has recommended temporary ...
Posted by Michael Wonder on 28 Oct 2021
Mallinckrodt and Terumo Blood and Cell Technologies announce positive recommendations in Australia for public funding of Uvadex (methoxsalen) for ECP administration with the Therakos Cellex photopheresis system for chronic graft versus host disease in adults
28 October 2021 - In a dual review process, two independent advisory committees to the Australian Minister for Health recommended reimbursement ...
Posted by Michael Wonder on 27 Oct 2021
Audrey Ashman’s bone treatment for rare genetic disease known as XLH denied government subsidy
24 October 2021 - Audrey Ashman loves to ballet dance and plays with her brothers — but she needs a special ...
Posted by Michael Wonder on 26 Oct 2021
The challenges of inadequate financial support for Australians with cancer
21 October 2021 - The publicly funded Medicare system in Australia has been recognised as a leading universal health care model. ...
Posted by Michael Wonder on 24 Oct 2021
DoH publishes yet another revised version of the agenda for the November 2021 PBAC meeting
25 October 2021 - We make this version number 10. ...
Posted by Michael Wonder on 24 Oct 2021
Breast cancer treatment expanded on the Pharmaceutical Benefits Scheme
24 October 2021 - The Morrison Government is helping improve access to an important treatment for Australians battling a form of ...
Posted by Michael Wonder on 19 Oct 2021
Strategies for generic/biosimilar market entry in Australia
19 October 2021 - After surviving the Great Patent Cliff of 2011–2016, the pharma/biopharma industry finds itself in the Second Great ...
Posted by Michael Wonder on 18 Oct 2021
Australia secures additional COVID-19 treatments
17 October 2021 - The Australian Government has secured access to two additional COVID-19 treatments to support the National Plan to ...
Posted by Michael Wonder on 17 Oct 2021
Recommendations made by the PBAC – September 2021 intracycle meeting
15 October 2021 - First PBAC recommendation for a new gene therapy. ...
Posted by Michael Wonder on 15 Oct 2021
Recommendations made between March 2021 and November 2021 PBAC meetings
15 October 2021 - Recommendations made by the PBAC between the March 2021 and November 2021 have been published. ...
Posted by Michael Wonder on 15 Oct 2021
Updates to the procedure guidance for listing medicines on the PBS
15 October 2021 - The Department has updated Section 5.8 New brand of existing pharmaceutical item submissions (not requiring PBAC consideration) ...
Posted by Michael Wonder on 14 Oct 2021
Pharmacists opt out of third shot as doses of vaccine set to expire
14 October 2021 - The rollout of third doses of the COVID-19 vaccine to thousands of immunocompromised people has been ...
Posted by Michael Wonder on 12 Oct 2021
Vaccinations can end political blame game: CSL
13 October 2021 - CSL chief Paul Perreault has warned that the politicisation of Covid-19 is fuelling vaccination hesitancy as ...
Posted by Michael Wonder on 12 Oct 2021
DoH revises agenda ahead of new month's PBAC meeting
12 October 2021 - One minor change. ...